Clinical Trials Browser

Metastatic Castration-resistant Prostate Cancer × afuresertib × Genitourinary × Clear all

NCT04060394 2024-10-10

Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC

Phase 1/2 Completed

Metastatic Castration-resistant Prostate Cancer